Motif Neurotech's Innovative Approach to Depression Treatment Gains FDA Approval

Motif Neurotech, a neurotechnology startup, has garnered FDA approval to initiate a feasibility trial for a novel brain implant designed to address depression.

This approval allows the company to explore the potential of its innovative approach in treating a condition that affects millions.

The trial will assess the safety and efficacy of the brain implant, potentially paving the way for new treatment options in mental health care.